Combination Osilodrostat and Cabergoline in Cushing's Disease
Clinical trial NCT07603466 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07603466
- Sponsor
- University of Basrah
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-11
- Primary completion
- 2028-06-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.